We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of LifeSci Acquisition Corp. (“LifeSci” or the “Company”) (NASDAQ: LSAC) with Vincera Pharma, Inc. (“Vincera”). The terms of the merger, current stockholders of Vincera will own approximately 40% of the combined company.
The LifeSci merger investigation concerns whether the Board of LifeSci has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.
To receive more information, please fill out the form.